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Abstract
Fractures are among the most common human traumas. Fracture healing represents a unique temporarily definable post-
natal process in which to study the complex interactions of multiple molecular events that regulate endochondral skeletal
tissue formation. Because of the regenerative nature of fracture healing, it is hypothesized that large numbers of post-natal
stem cells are recruited and contribute to formation of the multiple cell lineages that contribute to this process. Bayesian
modeling was used to generate the temporal profiles of the transcriptome during fracture healing. The temporal
relationships between ontologies that are associated with various biologic, metabolic, and regulatory pathways were
identified and related to developmental processes associated with skeletogenesis, vasculogenesis, and neurogenesis. The
complement of all the expressed BMPs, Wnts, FGFs, and their receptors were related to the subsets of transcription factors
that were concurrently expressed during fracture healing. We further defined during fracture healing the temporal patterns
of expression for 174 of the 193 genes known to be associated with human genetic skeletal disorders. In order to identify
the common regulatory features that might be present in stem cells that are recruited during fracture healing to other types
of stem cells, we queried the transcriptome of fracture healing against that seen in embryonic stem cells (ESCs) and
mesenchymal stem cells (MSCs). Approximately 300 known genes that are preferentially expressed in ESCs and ,350 of the
known genes that are preferentially expressed in MSCs showed induction during fracture healing. Nanog, one of the central
epigenetic regulators associated with ESC stem cell maintenance, was shown to be associated in multiple forms or bone
repair as well as MSC differentiation. In summary, these data present the first temporal analysis of the transcriptome of an
endochondral bone formation process that takes place during fracture healing. They show that neurogenesis as well as
vasculogenesis are predominant components of skeletal tissue formation and suggest common pathways are shared
between post-natal stem cells and those seen in ESCs.
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Introduction
Fractures are among the most common traumatic injuries in
humans and osteoporosis related fractures are the fastest growing
health care problem of aging [1]. The vast majority of fractures
sustained worldwide are either untreated (e.g. patients in many
third-world countries) or are treated in a manner that involves a
periosteal response and a process of endochondral bone formation
[2–4]. In contrast to most injury responses that lead to fibrotic
scarring and incomplete restoration of tissue structure, fracture
healing restores both structure and cell composition and in this
regard is a true regenerative process. Over the time course of
fracture healing, multiple cellular lineages that give rise to
cartilage, bone, vascular, and hematopoietic tissues that make up
a skeletal organ, are all recruited and contribute to the
regeneration of the injured skeletal organ [5–9]. Because callus
tissue formation is temporarily and spatially definable, fracture
healing represents a unique process in which to study the complex
interactions of the multiple molecular events that regulate
endochondral bone formation.
Studies in different strains of mice have shown that there are
genetically inherited variations in both the quantitative levels and
the timing in expression of the transcription factors that control the
differentiation of chondrogenic and osteogenic lineages during
fracture healing process [10]. A large number of studies have
shown that many of the individual morphogenetic factors and
their receptors that control the embryonic development of skeletal
tissues, such as Wnts, BMPs and FGFs, are also expressed during
fracture healing [11–17] and that the manipulation of the
expression of these morphogenetic factors will effect skeletal cell
differentiation and the rate of fracture healing [11,15–17]. The
regenerative nature of fracture healing, the appearance of the
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primary morphogenetic factors that have been associated with
embryological development of skeletal tissues, and the inherited
nature in developmental variations of bone formation are all
supportive of the generally held hypothesis that post natal fracture
healing recapitulates the embryonic developmental processes that
originally formed the injured skeletal tissues [5–7]. Consistent with
this hypothesis is the general presumption that large numbers of
stem cells are recruited and contribute to the development of the
multiple cell lineages that contribute to bone healing.
A number of studies have exploited the unique spatial and
temporal nature of callus formation to carry out large scale
transcriptional profiling approaches to examine the expression
characteristics of the transcriptome during the endochondral process
of bone formation, which is observed during fracture healing. These
previous studies however have shown two primary limitations: 1)
either the number of time points that were used in their comparisons
have been limited or; 2) very limited assessment approaches were
used to relate the expressed genes to functional ontologies associated
with specific cell lineages, biological processes, and molecular
pathways [18–21]. As the use of transcriptional profiling has become
more wide spread and as genomic and expression data bases have
grown in scope, new technical approaches have been developed to
more fully analyze and interpret large scale transcriptional profiling
studies. The current study uses Bayesian modeling that clusters the
expressed genes into groups that show temporally concurrent
expression over multiple time points spanning a 21 day period of
fracture healing. Multiple analyses were then carried out that
defined the temporal dynamics of gene expression that were
associated with various cell lineages, biological processes, regulatory
and metabolic pathways. In this study, we also specifically define
those Wnt, BMPs, and FGFs and their receptors that showed
differential expression over the time course of fracture healing and
related the expression of these genes to major groups of
transcriptional regulators that were concurrently expressed with
each of these families of morphogenetic genes. In order to determine
if the patterns of expressed genes during fracture healing were
reflective of stem cells, we compared the set of genes that were
differentially expressed during fracture healing to the expression sets
that are associated embryonic stem cell and mesenchymal stem cells.
Finally, we place the expression of 174 of the 193 genes known to be
associated with human genetic skeletal disorders in the context of
their temporal expression during the process of endochondral bone
formation that is seen during fracture repair.
Materials and Methods
Surgical Models
Research was conducted in conformity with all Federal and
USDA guidelines, as well as an IACUC approved protocol. All
studies were performed on male 8–10 weeks old C57 BL/6J (B6)
mice. Age, sex, and genetic strain of mice were based on previous
data, in which the time course of fracture healing had been
established by both histological and selected candidate gene
assessment [8–11]. Simple transverse closed unilateral fractures in
the left femur of all mice were made using a modification of the
method of Bonnarens and Einhorn [22], as previously described
[10]. Surgical marrow ablation was carried out by reaming of the
marrow space as described in Gerstenfeld et al., 2001 [23], using
15 week old male mice based on a modification of the method of
Suva et al., 1993 [24], that had been developed for rats.
MSC Culture and Osteoinduction
Marrow stromal cell cultures were prepared from C57 BL/6J
(B6) male mice of 8–10 weeks of age (Jackson Laboratories, Bar
Harbor, ME) and osteoinduction of these cultures as carried out as
previously described [25].
Murine Embryonic Stem Cell (ESC) Culture
Murine embryonic stem cells (E14.1; 129/Ola) [26–28) were
maintained in the undifferentiated state by culturing in serum-free,
feeder-free conditions as published [17]. This ESC line contains
two knock-in reporter genes (Bry-GFP and Foxa2-hCD4) to allow
monitoring of the differentiation state of cells in culture [26].
Briefly, the undifferentiated ESC were cultured on gelatin-coated
6-well plates in maintenance media1 consisting of 50% Neurobasal
medium (Gibco-BRL) and 50% Dulbecco’s Modified Eagle
Medium/F12 medium (Gibco-BRL); with N2 and B27 supple-
ments (Gibco-BRL), 1% penicillin/streptomycin, 0.05% bovine
serum albumin, LIF (1000u; ESGRO; Chemicon), 10 ng/ml
human BMP-4 (R&D Systems), and 1.5 1024 M monothioglycerol
(MTG) (Sigma).
Murine Embryonic Fibroblast Cultures
Primary mouse embryonic fibroblasts (MEFs) were obtained
using standard culture methods [29] for their isolation and
expansion, from E13.5 mouse embryos (Charles River; strain
#023; CF-1). Briefly, whole embryos were minced and trypsinized
cells released from the tissue digestion were plated in fibroblast
complete media (DMEM with 10% FBS; 1% penicillin/strepto-
mycin and L-glutamine). Non-adherent cells were discarded, and
plastic-adherent cells were serially passaged to purify and expand
MEFs. All results shown are from passage 5 MEFs.
RNA Preparation
After euthanasia, fracture sites were circumscribed by 5 mm on
either side of the break. An identical region of tissue was excised
from the mid half of the unfractured femora which was used as the
control. Marrow ablation specimens were prepared by removing
the distal cartilage condylar surfaces of the operated tibia and
cutting approximately at the center of the mid-diaphyseal region.
All bone tissues were collected into liquid nitrogen and stored at
280uC until used for RNA extraction. RNAs to be used for
microarray were prepared as previously described [18]. RNA was
prepared from cell cultures using the same basic procedure used
for intact tissues except that at the time of harvest, the cell layers
were directly scraped up into TrizolH (Invitrogen Carlsbad, CA)
reagent and either directly extracted or frozen at 280uC
Logistics of Transcriptional Profiling Analysis
The basic technical approaches that were used in these studies
are presented in Wang et al., 2006 [18]. A flow chart of the steps of
this array analysis is presented in Figure 1. Large Scale
transcriptional profiling was carried out on total RNAs that were
collected across temporal profiles of fracture healing from C57 B6
mice. Specifically, we chose to study the expression profiles at day
0, 3, 5, 10, 14, and 21, where day 0 corresponds to unfractured
bones and is used as the biological reference. For each time point,
RNA from 5 mice was pooled and hybridized in quadruplicates,
using a dye swap design to produce 4 expression measurements
per time point.
Microarray Hybridization and Image Analysis
Labeled samples were hybridized to slides containing the
Operon Mus musculus probe set (Qiagen) of ,21,000 70-mer
oligonucleotides. All slides were co-printed with an internal
‘‘alien’’ sequence that has no sequence homologues in the mouse
genome. Use of this alien allows an independent data set of
Fracture Healing Transcriptome
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absolute ratios of the individual hybridization intensities to be
developed. Slide printing, array labeling, hybridization, and slide
reading were performed at the Massachusetts General Hospital
Genomics Core Facility as previous described [21]. All slides were
quality control tested and contain appropriate positive and
negative control sequences for data analysis. Ratio Intensities
(RI) were directly determined by either using the cDNA produced
from the unfractured bone as the biological reference or by using
the externally added alien mRNA transcript as the reference. The
alien gene in these studies serves as both a genome-extrinsic
sequence and universal in-spot reference. In the experiments
reported here, all microarrays were printed in which an alien 70
mer probe was co-printed with the different gene specific probes
such that the alien was at a final concentration of 10% of the
murine gene oligonucleotides. Hybridization was then carried out
with cDNAs containing the complementary sequence of the alien
oligo labeled with Alexa-488. This sequence was included into
each of the two different nucleic acid test samples (RNA isolated
from C57B6 mouse callus tissues and RNA isolated from C3H
mouse callus tissues) that had been labeled with Cy3 and Cy5,
respectively. There is in all four technical replicates with two dye
swaps between the two strains of mice. Only data for the C57B6
strain is presented in this paper. All labeling was performed using a
modified protocol of the Atlas Power script Fluorescent Labeling
Kit (Clontech Cat # K1860-1). After labeling and slide
hybridization, data was collected. A GenePix 4000B microarray
scanner and software (Axon Instruments) were used to quantify
micro arrays. Microarray data was stored and further quality
controlled using the BioArray Software Environment (BASE).
Raw and normalized data values are available through EBML-
EBI repository, to be released in July 2009.
Data Normalization and Filtering
Background was calculated locally per spot and subtracted from
the intensity measurement of each hybridized spot. After
background correction, negative expression values were removed
and the data were normalized by scaling all individual intensities
to a fixed target. Probes with less than 10 positive values after
background correction were disregarded and the remaining
expression data were normalized to the appropriate referent
group. Final summaries per time point were computed as the
average of the log10 normalized expression values.
Post Array Data Analysis
The analysis of normalized values was carried out using the
Cluster Analysis of Gene Expression Dynamics Program
(CAGED, http://genomethods.org/caged/) [30]. The program
uses a Bayesian models based clustering procedure to group genes
into clusters, where genes assigned to the same cluster have the
same temporal expression profile and therefore are likely to have
similar functions, or common regulation. The clustering algorithm
uses Bayes theorem to compute the probability that genes belong
to the same cluster and details are described in Ramoni et al., 2002
[30]. A feature of the method is to use a cluster search procedure
that automatically identifies the optimal number of clusters. We
used the default setting of the program and filtered out all probes
in which the temporal profile was always within 2 fold of
expression from the referent group as our sample size does not
allow reliable estimate of small effects [31]. We used polynomial
models of degree 4 for modeling the temporal expression profiles
that are better suited to describe short patterns [32]. Goodness of
fit of the resulting model was assessed by checking the normality of
the standardized residuals of each cluster.
The clusters are summarized by the average expression profiles,
per cluster, that is plotted against time (See Figure 2). This profile
is computed as the average of expression, per time point, of all
genes assigned to the same cluster.
The clusters of genes identified by CAGED were analyzed using
the gene set enrichment analysis in David Bioinformatics resources
Huang da et al., 2007 [33] (http://david.abcc.ncifcrf.gov/home.
jspand), and Hosack et al., 2003 [34]. Only gene groups having an
enrichment score #.05 were considered in this analysis. The
ontologies with overlapping gene sets were manually annotated
and grouped together into larger functional groupings (seen below
in Figure 3 and Figure 4) that are summarized in Table S1 and
Table S2.
Candidate mRNA Expression Analysis
RT-PCR. All reagents for the PCR analysis were from
Applied Biosystems, Inc., and plate assays were read in an ABI
7700 Sequence Detector (Applied Biosystems, Foster City, CA).
The methods of DNA amplification were as previously described
[18]. All samples were run in triplicates of pooled mRNAs from
five mice for in vivo experiments. Cell culture measurements were
from N=6 derived from triplicates of two separate cell
preparations. All reagents for the qRT-PCR analysis were from
Applied Biosystems, Inc. Two mg of total RNA was used for each
preparation of cDNA. All cDNA preparations were generated by
random hexamer priming. Pertinent sequence information and
amplicon sizes for all Taqman gene expression assays used in this
Figure 1. Flow chart of the logistics of the array analysis. Each of
the major technical steps of the analysis is boxed. Arrows show the
linear progression of the individual steps taken during the analysis.
Programs used for each stage of the analysis are indicated in the
parenthesis.
doi:10.1371/journal.pone.0005393.g001
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study are available for each target gene from Applied Biosystems,
Inc. (https://products.appliedbiosystems.com/ab/en/US/adirect/
ab). Each plate contained two negative controls and a positive
control probe. All mRNA levels were normalized to b-actin and
each analysis was run in triplicate. The fractional cycle number at
which the fluorescence passes the fixed threshold (CT values) was
used for quantification by using a comparative CT method. This
method is described within the Applied Biosystems, Inc. instruction
manual for the instrumentation. Sample values are then normalized
to the threshold value for bactin (Actb) for each time-point: DCT =
CT (exp)2CT (Actb). The CT value for day 0 was then used as a
reference. DDCT = DCT (exp)2DCT (exp day 0). The fold change
in mRNA expression for each time point was plotted in a graph
using day 0 as a reference: 22DDCT (day 0) = 1.
Results
On Overview of the Temporal Dynamics of
Transcriptional Activity during Fracture Healing
The set of data summarizing the total complement of expressed
mRNAs in unfractured bone and within callus tissues at various
times post fracture are summarized in Table S3. 11,432 mRNAs
out of ,18,346 expressed genes showed changed levels of
expression across the time course of fracture healing at a non
log transformed value of greater than +/22 to unfractured bone.
Based on these values and the current estimates of ,38,000 genes
in the mouse genome [35], these data suggest that a little over one
half of the complement of genes expressed in the mouse genome
were differentially regulated during fracture healing, while ,80%
of the mouse genome is expressed at a detectable level in skeletal
organs. The Log ratio intensity values based on normalization to
the in spike alien sequence control is also presented in Table S3.
The externally normalized expression values to the co spotted
alien sequence can be used to extrapolate copy number of
expressed genes in the bone tissues. Approximately ,10% of the
gene descriptors in the array represent multiple splice variants that
can also be deduced from the nucleotide sequences (Table S3). An
example of the set of splice variants seen for the Runx2 is shown in
the Figure S1. These results are used to provide a demonstration of
how copy number values can be extrapolated from the externally
normalized expression values.
The graphical appearance of the fifty five unique temporal
clusters that were generated using the cluster analysis is seen in
Figure 2 and a schematic of the general biological processes of
murine fracture healing based on prior studies [8–11,18,36] is
presented in the legend (bottom right). Twenty seven of these
clusters showed patterns of increased expression across two or
more time points and 18 clusters showed patterns of decreased
expression across all time points. The remainder of the clusters
were arranged in a variable group. Assignment to this group was
based on two criteria. The first was that the cluster showed a
pattern of increased or decreased expression at a single time point.
The second criterion was that the expressed genes in the cluster
showed a statistically relevant association with a biological
ontology related to T cell function.
The pie graphs provide a global overview of the biological
processes that were altered as a consequence of fracture (Figure 3).
All biological ontologies that were identified and having a p#.05
were individually examined and those that contained overlapping
sets of genes and which were representative of redundant functions
were grouped together for the simplified presentations of the pie
graphs (see Materials and Methods and Table S1). The biological
functions showing the largest percentage change across the whole
time course of fracture healing were those associated with various
developmental processes, specific elements of metabolism, and
components of both intracellular and extracellular signaling. The
three general groupings of the expression data showed that there
were distinct differences that would define the cell or tissue types
seen in each of these three broad groupings. Expression of genes
associated with processes of vasculogenesis (V), neurogenesis (N),
skeletogenesis (S), myogenesis (M), and gametogenesis (G) were all
seen in the Up group of clusters. Gene expression associated with
neurogenesis and vasculogenesis overlapped with the expressed
groups of genes associated with all of these other tissue types,
suggesting that the development of vascular and neural tissues
were both concurrent and co-regulated with these other tissues. All
of the clusters of the variable group had gene ontologies related to
T-Cell functions. The variable group also contained some
ontologies that were also associated with neurogenesis and
vasculogenesis, but these are not denoted. The down clusters
were selective for functional groups associated with myelopoiesis,
specific aspects of T-cell function, B cell maturation and
erythropoiesis.
Other processes, showing altered expression during fracture
healing included the up regulation of gene families associated with
cell adhesion (integrin based, gap junction based, and cadherin
based) and actin cytoskeletal functions, while the variable group
showed genes associated with motility related to expression of
chemokimes, histocompatibility, innate immunity, antigen presen-
tation, and stress response. The down regulated groups encom-
passed the biological processes associated with biotic defense
responses, negative cell cycle regulators associated with DNA
repair processes and erythropoiesis. Two other much more
targeted types of analysis were carried out from these data. The
first was to identify those ontologies associated with various
metabolic functions that were distributed in the three temporal
groupings of expression (Up, Down, or Variable). The list of these
ontologies is seen in Table 1. The second analysis focused on the
types of signal transduction or regulatory pathways that are
associated with the expressed genes in the Up, Down, or Variable
groups. This was carried out by comparing the gene expression
data in the three groups to those pathway gene sets that have been
defined in the Kyoto Encyclopedia of Genes and Genomes
(KEGG) Pathways (http://www.genome.jp/kegg/pathway.html).
The list of those pathways showing statistical significance in their
expression across fracture healing is presented in Table 2.
A large number of key regulatory mechanisms effecting skeletal
tissue development have been identified over the last fifty years
through the study of human congenital diseases [37]. Because
many of these genes effect a wide variety of organ systems and do
not have an overt relationship to skeletal tissue development, the
Figure 2. Temporal profiles of gene expression across fracture healing. Expression profiles of the temporal clusters produced by the Baysian
modeling are presented. The three major groups of gene expression patterns (UP, Down and Variable) based on their temporal patterns of expression
are presented. Biological ontologies associated with the development of specific tissue types (N = neurogenesis, V = vasculogenesis,
S = Skeletogenesis, G =Gametogenesis) are indicated in the figure. All clusters in the variable group are specifically associated with T cell or B cell
function or development. The underlined number is the cluster upper number is the total expressed genes in a cluster and lower number is the
number of genes associated with ESCs. A diagrammatic presentation of the general biological stages of murine fracture healing, duration and relative
scale of each stage are denoted in the figure in the lower right corner of the figure.
doi:10.1371/journal.pone.0005393.g002
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analysis of their expression in fracture healing offers the unique
possibility of identifying either the developmental stage at which
the they effect skeletal tissues, or the potential co-interacting genes
that provide complementation to the development of the skeletal
phenotype. A basic assessment of all the currently known genes
associated with human skeletal disorders was carried out to
identify those known genes that are associated with congenital
skeletal deficiencies that are differentially expressed during fracture
healing. These data are summarized in Table S4 including the
cluster that the gene is associated with and the major tissue
ontologies associated with the cluster, and the type of phenotype
that is displayed when the gene is mutated. Of the 193 genes that
are currently classified as being associated with congenital disorder
of skeletal tissues [37], 174 were shown to be present in the array
profiles and 147 showed two fold or greater difference in
expression during fracture healing. These data demonstrate that
a number of types of disorders show associations with both unique
temporal clusters and/or biological processes that are related with
a given cluster. Thus, the genes associated with epiphyseal and
metaphyseal dysplasias are almost all associated with clusters 1, 4,
and 35 and these clusters are all associated with skeletogenesis and
contain a preponderance of the expressed genes for extracellular
matrix proteins. On the other hand, almost all of the genes that are
associated with lysosomal disorders were associated with clusters
17 and 20 and these clusters were all associated with the
development of multiple tissues.
Temporal Relationships of the Expression of the BMP,
Wnt, and FGF Morphogen Families to the Selective
Expression of the Homeotic and Sox Transcription
Factors during Fracture Healing
The expression patterns of the major morphogenetic families of
proteins (BMPs, Wnts and FGFs) that are the known primary
regulators of skeletal tissue development are next presented. This
data is used as a means of validating that the temporal clustering
accurately models the expression and interactions of specific genes,
since the expression of many of these genes has been established
from studies of embryological and post natal endochondral bone
formation. The expression profiles of the BMP and Wnt gene
families are first presented in Table 3. The individual genes for all
of the expressed BMPs, Wnts, and their receptors are found in 11
clusters that are all in the unregulated group and are denoted in
the Table 3. The expressed genes are arranged into four temporal
sets: a set of from the clusters showing continuously unregulated
expression over the time course of fracture healing (clusters 29, 32,
and 35); a set from clusters showing a biphasic pattern that had a
peak of expression at day 3 followed by a later increases at days 14
and 21 (clusters 17, 20;and 21); a set showing a middle pattern in
which the genes had peak expression at 5 and 10 days (clusters 6
Figure 3. Distribution of biological functions associated with
three major temporal grouping of gene expression. Pie Graph
Distribution of biological functions was based on analysis of the three
major groupings of the temporal clusters as indicated in Figure 1 using
Database for Annotation, Visualization and Integrated Discovery
(DAVID). Only those biological functional ontologies with p,.05 were
considered with over lapping functions consolidated into single
categories as indicated in Table S1. The total number of genes within
each of the major groupings is indicated in the figure and percentage
distributions of the grouping were calculated as descried in the
materials and methods. A uniform color coding between the pie graphs
for the biological groupings was used for comparisons between the
groups.
doi:10.1371/journal.pone.0005393.g003
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and 7); and a late set of genes showing peak expression from days
14 to 21(clusters 5, 15, and 18).
A number of examples for the expression of specific genes in
these groups of clusters are presented to provide validation of the
Bayesian modeling. The first example is related to the group of
clusters that is expressed in the middle temporal period. The
expression of Bmpr1a, Bmprb, PthrP, and Ctgf within this
temporal grouping of clusters is concurrent with the initial
proliferative phase of chondrocyte development during fracture
healing and is consistent with both the known patterns of
expression of these genes and their functional interactions during
embryonic and growth plate endochondral bone formation [38–
40]. A second example is related to the biphasic set of clusters.
This set contained BMP 2, 4, 5, and 8a. We have previously shown
that this particular group of BMPs is all co-expressed and
regulated as a network during marrow stromal cell differentiation,
and this network is under the control of BMP2 [16]. The multiple
transcription factors that were identified in this set of clusters also
have been shown to be reciprocally co-regulated by BMP2 and
included Dlx5, Runx2, and Sp6 [41–44]. It is also of considerable
interest that the major Wnt co-receptors Lrp5 and Lrp6 that are
known to be associated with skeletal tissue development were also
co-expressed with these BMPs and each other in these clusters,
since a number of studies have shown the interaction of these
families of morphogenetic proteins during osteogenesis as well as
in embryogenesis [45–47]. A third example of the consistency of
the temporal expression data to the published literature is related
to the expression of BMP6 and Wnt 10b. These morphogens
have been implicated in the regulatory control of osteoblast/
adipocyte differentiation of the marrow stromal cells and are co-
expressed during coupled remodeling [48–49]. The late appear-
ance of their expression would be consistent with the initiation of
coupled remodeling during the first wave of primary bone
formation.
Figure 4. Distribution of biological functions associated with ESC genes identified as expressed during fracture repair. Two major
temporal grouping of gene expression (Up or Down) is presented in a pie graph. Distribution of biological functions was based on analysis of the
groupings of the temporal clusters as indicated in figure one using. Up and Variable groupings were consolidated together for analysis using
Database for Annotation, Visualization and Integrated Discovery (DAVID). Only those biological functional ontologies with p,.05 were considered
and those with over lapping functions were consolidated into single categories as indicated in Table S2. The total number of genes within each of the
major groupings is indicated in the figure and percentage distributions of the grouping were calculated as descried in the materials and methods. A
uniform color coding between the pie graphs for the biological groupings was used for comparisons between the groups.
doi:10.1371/journal.pone.0005393.g004
Table 1. Variations in Metabolic Activities in the General Temporal Groupings
Up Groups Variable Groups Down Groups
Glucose transport Arachidonic Acid (anabolic) Porphyrin (anabolic)
Prostaglandin (anabolic) Amino Acid Metabolism (modifying) Pentose (catabolic)
Lipid (anabolic) Amine Metabolism (anabolic) Purine (catabolic)
Amino acid (anabolic) RNA Metabolism (polymeric anabolic) Pyrimidine (catabolic)
Nitric Oxide Pyrimidine (catabolic) Gluconeogenesis
Hexose transport Alcohol catabolism
Catecholamine Pyruvate metabolism (anabolic)
Dopamine
Glucosamine
doi:10.1371/journal.pone.0005393.t001
Fracture Healing Transcriptome
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In the context of the expression of the BMP and Wnt
morphogen families, these data also demonstrate that large
numbers of homeotic transcriptional regulators and multiple
members of the Sox family not previously shown to be post-
natally expressed are seen during fracture healing. All of the Sox
family members that were expressed, during fracture healing
were isolated in the same clusters as the BMPs and Wnt families,
while over 95% of the observed homeotic genes that showed
altered expression during the time course of fracture healing were
also in these clusters. In summary, the data presented in Table 3
provide a strong validation of the Bayesian modeling by
demonstrating that the data had predictive value of many
previously identified interactions of genes that had been
examined in the context of their regulatory function in skeletal
tissue formation.
The summary of the expression data for the FGF family of
morphogenetic proteins and their receptors is presented in Tables
S5. Several interesting observations may be made from these
data. The first is that a large number of expressed FGF ligands
are down regulated during fracture healing. This implies that
these ligands must carry out functions in the normal bone tissue
that are down regulated during the fracture healing process. The
second observation is that all four FGF receptors and their splice
variants are unregulated during fracture healing and their
expression overlaps completely with the same clusters in which
the BMPS and Wnts and their receptors are expressed. In
contrast, while some of the FGF ligands are expressed in the same
clusters as the Wnts and BMPs, a number of the FGF ligands are
not. Finally, a large number of FGF isotypes that are differentially
expressed during fracture healing are identified, which have not
to date been characterized in the context of skeletal tissue
formation.
Multiple Genes Preferentially Expressed in ESCs Are
Expressed During Fracture Healing
Since it may be speculated that large numbers of post natal stem
cells are recruited during fracture healing, we sought to assess
whether the transcriptional expression profiles seen during fracture
healing would contain many of the genes that are preferentially
expressed by stem cell populations. This question was first queried
by carrying out a comparison of ,12,000 genes showing a .2 fold
change in the callus tissues to the set of genes that are preferentially
expressed in embryonic stem cells (ESCs) [50]. This analysis
identified that,300 out of,1000 genes known to be preferentially
expressed in human embryonic stem cells (ESCs) were upregulated
during fracture healing, while an additional ,100 genes that
showed preferential expression in ESC were downregulated. The
distribution and numbers of these expressed genes within the
different clusters of fracture healing are depicted in Figure 4. Table 4
presents a list of 17 genes common in ten or more transcriptional
profiles of ESCs that are preferentially upregulated in fracture
repair. We then compared two other transcriptional analysis studies
that had defined those genes that showed preferential expression
either in embryonic or post natal cell populations of MSCs [51,52].
Table 5 identifies that subset of expressed genes common in fracture
repair, ESCs, embryonic MSCs and post embryonic MSCs, and
fracture healing. Only one expressed gene (methyl-CpG binding
domain protein 2) overlaps between all four published expression
profiles, while there was overlap between 12 expressed genes
observed in ESC and embryonic MSCs. Table S6 presents the
complete data sets comparing fracture callus mRNA expression to
the three types of stem cells.
Figure 4 presents the graphic distribution of biological
ontologies that are associated with the distribution of ,300
upregulated and ,100 down regulated genes that are expressed in
Table 2. Identified KEGG* Pathways in the General Temporal Groupings
Up Groups
No.
Genes Variable Groups
No.
Genes Down Groups
No.
Genes
ECM-receptor interaction 47 Antigen processing and presentation 15 Cell cycle (Negative Regulators) 35
Cytokine-cytokine receptor interaction 99 Arachidonic acid metabolism 9 Pentose phosphate pathway 12
Axon guidance 57 B cell receptor signaling pathway 8 Hematopoietic cell lineage 24
Melanogenesis 45 Cell adhesion molecules (CAMs) 16 B cell receptor signaling pathway 20
Focal adhesion 78 Cytokine-cytokine receptor interaction 27 Pyrimidine metabolism 23
TGF-beta signaling pathway 40 Glycine, serine and threonine metabolism 7 MAPK signaling pathway 51
Cell Communication 54 MAPK signaling pathway 23 Fc epsilon RI signaling pathway 20
Adherens junction 33 Natural killer cell mediated cytotoxicity 18 ABC transporters - General 13
Basal cell carcinoma 25 Pyrimidine metabolism 11 Leukocyte transendothelial migration 26
Complement and coagulation cascades 30 T cell receptor signaling pathway 12 Natural killer cell mediated cytotoxicity 27
Hematopoietic cell lineage 34 Type I diabetes mellitus 12 DNA polymerase 9
Glycan structures - degradation 14 VEGF signaling pathway 10 Melanoma 17
Olfactory transduction 14 Purine metabolism 27
GnRH signaling pathway 36 Porphyrin and chlorophyll metabolism 9
Renin-angiotensin system 10 Carbon fixation 7
Hedgehog signaling pathway 22 Focal adhesion 34
Sphingolipid metabolism 16 VEGF signaling pathway 15
Wnt signaling pathway 52
Gap junction 34
*Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways (http://www.genome.jp/kegg/pathway.html)
doi:10.1371/journal.pone.0005393.t002
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the fracture callus tissue. The biological processes related to
specific tissues that were seen in the UP group were those
associated with neurogenesis and vasculogenesis. A very large
group of genes were also associated with nucleoli and mitochon-
dria organelle assembly and regulation of cell cycle control.
Interestingly, a number of genes that are preferentially expressed
in ESCs and which are seen in unfractured bone are downreg-
ulated after fracture. These genes are predominantly associated
with negative regulatory mechanisms associated with cell cycle
progression and DNA packaging. In the context of the nature of
these gene’s functions, it might be speculated that their
downregulated expression from a basal level of expression in
unfractured bone may be representative of the changes in
expression of the quiescent population of stem cells as they are
mobilized from their niche.
Assessment of Two Candidate Stem Cell Associated
Genes (Nanog and Methyl-CpG Binding Domain Protein
2) during in Skeletal Tissue Repair
The final set of studies were directed at validating the expression
of two different candidate genes Nanog and Methyl-CpG binding
domain protein 2. The data related to Nanog is first presented
Table 3. TGFb and Wnt Families of Expressed Ligands Receptors, Antagonists, Second Signals, and Transcription Factors
Temporal Pattern
Clusters Continuous Biphasic Middle Late
29/32/35 17/20/21 6/7 5/15/18
BMP Wnt TF* BMP Wnt TF BMP Wnt TF BMP Wnt TF
Receptors Acvr1 Fzd6 Sox16 Acvr2 Fzd4 Sox4 Bmpr1a Sox3 Fz8 Sox2
Tgfbr2 Fzd2 Acvr2b Fzd5 Sox7 Bmpr1b Sox5 Sox5
Tgfbr1 Fzd3 Sox10 Sox8 Sox9
Tgfbr2 Sox12 Sox14
Tgfbr3 Sox17
Bmpr2 Sox18
Ligands Tgfb3 Lrp1 Prrx1 Bmp4 Lrp12 Hoxa3 Pax1 Bmp15 Lrp12 Pax6
Bmp1 Wnt5a Prrx2 Bmp2 Lrp5 Hoxa4 Pax8 Bmp6 Wnt11 Pax7
Wnt2 Hoxa4 Bmp5 Lrp6 Hoxa10 Pitx3 Gdf5 Wnt2b Pitx2
Hoxa11 Bmp8a Lrp4 Hoxb1 Prrx1 Gdf7 Wnt7b Hoxa1
Hoxb2 Gdf9 Wnt5b Hoxb13 Wnt9a Prrx2 Wnt10b Hoxa2
Hoxb8 Gdf10 Wnt8b Hoxc6 Wnt9b Hoxa4
Hoxc8 Hoxc10 Hoxa5
Hoxd3 Hoxb3
Antagonists Inhbb Nog Hoxd13 Inhba Dkk3 Inhbe Hoxb6
Chrd Sp7 Sp6 Inhbb Wif Rbp1 Hoxb9
Bambi Msx2 Twsg1 Ror1 Hoxc5
Dlx5 Dlx5 Ror2 Hoxd3
Mdfi Dlx6 Hoxd9
Nfatc1 Mdfi
Runx2 Nfatc2
Snai1 Ptch1
Second Smad1 Twist1 Smad3 Catna Runx1 Smad4
Signals Nf1 Smad5 Catnb Runx2 Smad5
Twist1 Smad6 Nf1 Smad7
Nf2
Rora Rora Rara Rarg
Thra Tshr
Sstr1 Sstr5
Sstr2
Other Descriptors Rank Apase Rankl Flt1 Jag Ghr Mint Pou2f2 Calcb Egf Calcr
Bsp Igf1 Opn Creb1 Igfr2 Pou6f1 EgfrlGf1 Vegfc Crem Shox2
Jag2 Dmp Csf1 Hif3a Crem Mmp9 Ctgf1 Creb3 Pou2f1 Sdfr2
Col1a1 Nrp1 Col5a1 Dcn Ngfr PthrP Pou5f1 Lmx1
Oscar Bgn Wisp1 Wisp2 Pparg
Minor splice variant by quantitative expression are denoted by italicized text. * Transcription Factors
doi:10.1371/journal.pone.0005393.t003
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since it has been shown to be a central component in maintaining
pluripotency of ESC and is related to repression of ESC response
to BMP signaling [53]. The expression of Nanog was examined in
both an endochondral model of bone formation (fracture healing)
and a model predominated by intramembranous bone formation
(marrow ablation). The expression of Nanog was compared to that
of BMP2 and BMP4, since elevated BMP levels were shown to
promote ESC differentiation [54,55] (Figure 5). Both models
showed multiple peaks of Nanog expression. Comparison of the
fold differences in expression from their base lines showed that the
post fracture levels of induction were almost ten fold greater than
marrow ablation, with a ,40 fold induction seen in fracture and
maximal induction of ,4 fold seen in marrow ablation. In both
models of injury induced bone formation, each peak of Nanog
expression was generally followed or concurrent with a peak of
BMP2 and BMP4 expression.
Since the marrow ablation and fracture callus tissues from which
the RNAs were purified contain complex mixtures of multiple cell
types, it was unclear if Nanog expression would be representative of
populations of cells that contribute to skeletal tissue formation or
would be found in stem cells that give rise to other cell lineages. In
order to further address this question, the expression of Nanog was
examined over the time course of induction of osteogenesis of
marrow stromal cells in vitro (Figure 5B). Messenger RNA levels are
expressed relative to murine embryo fibroblasts (Mefs), considered
to be a null or a typical differentiated cell that has minimal Nanog
expression [56]. Nanog expression showed a ,50 fold peak at Day
6, the time when the last of the non adherent cells were removed
from the marrow cultures, but before they have been switched to
their differentiation media. As soon as the osteogenous was induced
and autogenously produced BMP2 levels rose, Nanog levels fell
during the terminal period of MSC differentiation. Panel C presents
a comparison of the peak levels of Nanog expression in MSCs,
fracture callus tissues and marrow ablation tissues relative to those
seen in Mefs or in comparison to ESCs. MSCs and fracture callus
tissues had ,50 fold greater expression than Mefs. While bone
tissues from marrow ablation showed levels of induction only five
fold those seen in the Mefs, the levels seen during skeletal tissue
repair were many fold over Mefs but still about ,20 fold less than
ESCs.
The final data that is presented is for the Methyl-CpG binding
domain protein 2 Gene expression (Figure 6). This gene was
examined since it was common to both MSCs and ESCs in the
three published studies to which we compared our expression data.
In our cluster analysis study, this gene showed a downregulated
expression over the time course until day 14, after which it
returned to slightly above its base line expression in unfractured
bone at day 21. When we looked at its expression by qRT-PCR
within the two in vivo models of bone healing a very different
pattern of expression from that seen for Nanog was observed.
Table 4. Selective Set of Upregulated Genes in Fracture Healing Common to ESC
Pou5f1(Oct4) POU domain, class 5, transcription factor 1 5
Dppa3 Developmental pluripotency associated 4 36
Sema6a Semaphorin 6A 25
Gal Galanin 36
Gabrb3 Gamma-aminobutyric acid (GABA) A receptor, beta 3 5
Sox2 SRY (sex determining region Y)-box 2 5
Lect1 Leukocyte cell derived chemotaxin 1 1
Nanog Nanog Homeotic gene 43
Cyp26a1 Cytochrome P450, family 26, subfamily A, polypeptide 1 16
Zic3 Zic family member 3 (odd-paired homolog, Drosophila) 19
Pim2 Pim-2 oncogene 37,22
Aass Aminoadipate-semialdehyde synthase 5
Usp9x Ubiquitin specific peptidase 9, X-linked (fat facets-like, Drosophila) 5
Crmp1 Collapsin response mediator protein 1 17
Bmpr1a Bone morphogenetic protein receptor, type IA 7
Orcil Origin recognition complex, subunit 1-like (yeast) 43
Gene Symbol* Name Cluster
*Listed genes seen in only 10 or more transcriptional profiles of ESC cells and common to that subset of genes up regulated during fracture healing.
doi:10.1371/journal.pone.0005393.t004
Table 5. Upregulated Genes in Fracture Healing Common to
MSC and ESC+
Pgk1 phosphoglycerate kinase 1 5
Rplp0 ribosomal protein, large, P0 9
Enah enabled homolog (Drosophila) (multiple splice variants) 17,21 35
Prdx1 peroxiredoxin 1 17
Uchl1 ubiquitin carboxy-terminal hydrolase L1 21
Tkt transketolase 23
Lmnb2 lamin B2 27
Calu calumenin (Calu), transcript variant 1 29
Cda cytidine deaminase 29
Dpysl3 dihydropyrimidinase-like 3 29
Tpm1 tropomyosin 1, alpha 29
Mbd2# methyl-CpG binding domain protein 2 13
Gene Symbol * Name Cluster
*Listed genes are common between that set of genes found in embryonic
MSCs, ESC, and showing upregulated expression in fracture healing [51,52]
#Common to ESC embryonic MSC and postnatal MSC
doi:10.1371/journal.pone.0005393.t005
Fracture Healing Transcriptome
PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5393
These results showed in both models that the expression of
Methyl-CpG binding domain protein 2 rose at much later periods
during bone healing than Nanog. Comparing the in vivo pattern
of expression to that seen during in vitro MSC differentiation
showed that its expression also increased late during the MSC
culture’s differentiation. This very different pattern of expression
from Nanog suggests that it may not be expressed by the same cell
populations as those expressing Nanog.
Discussion
An Overview of the Biological Processes of Response to
Fracture
A number of previous studies have used transcriptional profiling
approaches to identify novel candidate genes expressed during
fracture healing [18,57,58]. This study however is the first to
model the temporal profiles of gene expression and characterize
Figure 5. Comparison of steady-state Nanog mRNA expression relative to BMP2 and BMP4 mRNA expression levels over the time
course of bone development in different models post-natal skeletal tissue formation. (A) Two in vivo models of injury induced bone
formation. Fracture is presented on the left and marrow ablation is presented on the right. Time after fracture or surgical marrow ablation is indicated
in the figure. Nanog profiles are in the top panel and BMP profiles are in the bottom panels. RNA measurements are presented as a relative fold of
expression to day 0. Error bars = SD of three replicate measurements. (B) Relative mRNA expression of Nanog across the 21 time course of MSC
differentiation. Arrow indicates time point at which media was switched to differentiation promoting media containing 1028 M Dexamethasome,
5mM b-GPO4, and ascorbate. Inset shows the comparisons of BMP2 levels across the same time of MSC differentiation. Levels of Nanog expression
were made relative to murine embryonic fibroblasts while BMP levels were made in comparison to Day 0. c) Comparison of Nanog expression levels
between various in vivo models of injury induced of post natal bone formation and in vitro models of MSC differentiation. All levels of expression
were made at the time point at which maximal Nanog expression was observed. All levels are expressed relative to murine embryonic fibroblasts.
Fold difference to MEFs are indicted by the numbers over each bar. Groups are MEF= murine embryonic fibroblasts: Far left shows the levels of ESCs
for comparison. Differences in ESC scale are denoted by broken bar. Mean fold levels different from MEFs are numerically denoted above each bar in
the figure. Marrow Stromal Cells =MSCs. Fracture callus tissues at 14 days post fracture = FX: Marrow ablation tissues at 5 days post surgery = MAB.
Error bars = SD of three replicate measurements.
doi:10.1371/journal.pone.0005393.g005
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the biological processes and pathways of the gene expression over
the endochondral process of bone formation during fracture
healing. Bayesian model based clustering of the transcriptome was
used to establish the temporal relationships between the
development of the multiple tissues that make up skeletal organs
with the regulatory pathways and changes in tissue metabolism
during fracture healing. The general metabolic picture of bone
repair is one in which gluconeogenesis and nucleotide catabolism
are down regulated while glucose and hexose transport, aerobic
metabolism and the anabolic process involved in the synthesis of
amino acids, lipids, proteoglycans and RNA are all increased.
Several specialized metabolic processes show changed activities as
an immediate response to the injury such as arachidonic,
prostaglandin, and nitric oxide metabolism. On the other hand,
catecholamine and dopamine metabolism most likely are related
to aspects of neural tissue regulation and decreased porphyrin
synthesis likely reflects diminished erythropoiesis.
The various tissue types, major biological processes (Figure 3),
and various regulatory pathways (Table 1 and Table 2) that are
related to fracture healing were broadly identified in this study.
Although we do not provide an in-depth analysis of these data, an
example of how this data might be used is related to understanding
immune system response to injury. The fracture procedure used in
these studies produced a robust transient inflammatory and innate
immune response in an aseptic environment. In the context of this
injury, activation of the acquired system does not take place. It is
interesting to note however that groups of genes associated with B
cell receptor signaling, natural killer cell mediated cytotoxicity,
and T cell receptor signaling pathways are all transiently activated,
while a second group of genes in these same pathways are all down
regulated. Thus a comparison of the different sets of genes in these
pathways that are either up or down regulated, provide insight into
what gene expression is absent when acquired response activation
does not take place versus when tissue repair takes place. In this
context, recent studies have shown that bone marrow mesenchy-
mal stem cells exert considerable immune regulatory activity [59]
and in part are related to controlling autoimmunity. Finally these
data may provide considerable insight into the common
complication of immunosuppression that accompanies large
trauma to the skeleton [60].
The Role of Neurogenesis during Bone Formation
While it was anticipated that skeletogenic processes would
predominate during fracture healing, the number of genes
associated with vasculogenesis and neurogenesis associated
processes were five times more prevalent than those associated
with skeletogenesis. Genes associated with these biological
processes also appeared to be expressed earlier during fracture
healing than those associated with skeletogenesis and overlapped
into the genes sets that were identified to be common with ESC.
While it may be speculated that many of the developmental genes
that control neurogenesis and vasculogenesis will overlap with the
subset of genes associated with skeletogenesis, it is noteworthy that
large numbers of the expressed genes seen in the neurogenic
ontologies were unique structural elements associated with axon
formation and neural signal transduction. Such data suggest then,
that neurogenic tissues are also regenerated during fracture
healing, which has considerable implications in terms of using
this model to study specific aspects of post natal neural
regeneration.
The early temporal expression of large numbers of genes
associated with vascular and neurogenic tissue formation during
fracture healing is consistent with the very early and concurrent
development of these tissues during embryogenesis. In this context,
salamander limb regeneration does not occur in the absence of
accompanying neural tissue development [61,62]. Individual genes
that are upregulated during fracture healing that have been
associated with both neural tissue development and limb
development included N-Myc1 (neuronal myc) and the paired-
like homeodomain transcription factors. In the case of N-Myc1,
previous studies have associated this gene’s expression within
mammalian embryonic limb development [63], while the paired-
like homeodomain transcription factors that are identified in our
study have also been shown previously to be involved in
amphibian limb regeneration [62]. As an aside, it is interesting
to speculate that fracture healing is the phylogenetic descendant in
mammals of the ontological processes of limb regeneration seen in
amphibians.
Several studies have shown that bone and marrow tissues
contain both myelinated and non-myelinated fibers that enter the
bone along with blood vessels from the central feeding vessel along
with many smaller branches from the periosteum that all
terminate in the marrow space [64–66]. In a more recent study,
the autonomic innervation of the marrow space was mapped back
to the central nervous system [67] showing that there was central
control of the nerve fibers that innervated the marrow. Nerve
fibers containing neuropeptide Y2 [66] calcitonin gene related
peptide, substance P, and dopamine [68,69] have all been found in
bone tissues, and in a recent studies either germ line or specific
hypothalamic deletion of neuropeptide Y2 receptors has been
shown to lead to greater trabecular bone volume [70]. Finally,
multiple lines of evidence suggest that central neural control,
Figure 6. Comparison of steady-state mRNA expression levels of Methyl-CpG binding domain protein 2 over the time course of
bone development in different models post-natal skeletal tissue formation. Two in vivo models of injury induced bone formation, Fracture
(left panel) and marrow ablation (middle panel) are compared to the 21 time course of MSC differentiation (right panel). Time after fracture, surgical
marrow ablation, or time after plating in culture are indicated in the figure RNA measurements are presented as a relative fold of expression to day 0.
Error bars = SD of three replicate measurements.
doi:10.1371/journal.pone.0005393.g006
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integrally regulates aspects of bone marrow function and
immunological response [71,72] and a number of studies have
established that there is a central control mechanism that regulates
bone remodeling [73,74].
Commonality of Gene Expression between ESC and Post-
Natal Stem Cells
Fracture healing is generally believed to recapitulate embryolog-
ical mechanisms that formed the skeletal tissue. This raises the
question whether the post natal stem cells that contribute to this
repair process would express genes common with ESC or other
types of stem cells. In this regard, it is noteworthy that almost a third
of all genes that are preferentially expressed in ESCs are seen in
fracture callus tissues and that three of these genes Oct4, Sox2, and
Nanog, which play central regulatory roles in ESC maintenance
[53] are observed to be up regulated during fracture healing. Two
possibilities might explain the expression and functional role of these
ESC genes in post natal animals. One possibility is that populations
of stem cells persist from embryological development within the post
natal bone and that these cells maintain a pattern of embryological
gene expression that becomes apparent when large numbers stems
cells are mobilized and expanded during skeletal repair. Alterna-
tively, many of the genes that are expressed in ESC are induced by
injury within specialized post natal cell populations that contribute
to the regeneration of the skeletal tissues. While our observations do
not demonstrate functionality of these genes in a post natal context,
the examination of one of these genes Nanog was shown to be
induced in different forms of injury induced skeletal repair and
during marrow stromal cell differentiation in vitro. The biphasic
manner in which Nanog was expressed was also consistent with the
occurrence of separate waves of skeletal and hematopoietic stem cell
differentiation that occur during both fracture healing and marrow
ablation. Two recent studies suggest that there is a reciprocal
relationship between Nanog and BMP’s ability to promote
differentiation. In one study, Nanog was shown to block BMP-
induced mesoderm differentiation of ESC cells by interacting with
Smad1 and interfering with the recruitment of co-activators to the
active Smad transcriptional complexes thus preventing BMP
induced mesodermal differentiation of ESCs [54]. In the second,
more recent study the forced expression of Nanog in the C2
myogenic cell line did not alter terminal muscle differentiation but
prevented the osteogenic differentiation of these cells when treated
with BMP4 [75].
Lastly, we observed expression of large numbers of genes
associated with gametogenesis and gonad function during fracture
healing. While this observation is surprising, it is noteworthy that
spermatogonia arise in the only known post natal stem cell niche that
maintains a pluripotent stem cell population [53]. Thus our
observation offers the intriguing possibility that some of the biological
processes that maintain the spermatogonial stem cell niche may share
common features with those found within skeletal tissues.
In summary, these data present the first temporal analysis of the
transcriptome of an endochondral bone formation process that takes
place during fracture healing. Major observations include: the
extensive involvement of neurogenesis and vasculogenesis during
injury induced bone repair; the overlap in genes that are upregulated
to those that are preferentially expressed in ESC; and the
characterization of the temporal expression patterns of genes known
to be associated with various skeletal dysplasia during fracture healing.
Supporting Information
Figure S1 Comparison of Expression Profiles of Runx2 By Two
Methods of Normalization. An example of the set of splice variants
seen for the Runx2 is shown in Figure S1. These results are used to
provide a demonstration of how copy number values can be
extrapolated from the externally normalized expression values. A
comparison of the temporal expression of the four unique Runx2
transcripts based on the normalization of the expression data to
either day 0 no fracture or the in spike alien control is presented.
These data demonstrate the differences in the expression profile
data based on the two different approaches of expression
normalization. As can be seen from the data in which the values
were externally normalized to the alien control, the two mRNA
transcripts expressed in cluster twenty one were quantitatively the
most prevalent. Based on the oligonucleotide sequences and their
position in the genomic sequence four separate model sequences
for the Runx2 mRNA were predicted. The primary splice
differences in the exon arrangements for this mRNA were seen
in variations in the mid to 3 prime regions of the mRNA.
Interestingly the model prediction for the expressed transcript seen
in clusters 21 and 35 were similar. In contrast the predicted model
structure for the mRNA seen in cluster 32 showed an alternate
initiation site for the coding sequence. Top panel are expression
values based on normalization to the in spike alien oligonucleotide.
Bottom panel are expression values based on normalization to day
0 no fracture. The legend denotes the expression profile lines for
each of the four unique oligonucleotides used to assess splice
variants for the Runx2 gene.
Found at: doi:10.1371/journal.pone.0005393.s001 (0.04 MB
PDF)
Table S1 Identified Biological Ontologies Used To Define the
General Percentages of Functional Activities Across Fracture
Healing. Table S1 presents the individual biological processes that
were grouped together for presentation in Figure 3. The
percentages for representative ontology groups that were identified
using DAVID were determined for the total complement of
expressed genes contained in the up, down and variable group of
clusters (Table 4). Only those categories of biological processes
with p#.05 were considered and were sorted into categories
representative of overlapping processes. The individual genes were
identified for each biological process in a given group and a
complete list of all genes was compiled for each category and all
duplicates were removed. The percentage of each category was
computed by the genes per category over the total number of
genes for the three cluster subgroups included in Table 1 and
Table 2. The first sheet are the percentage distributions of the
consolidated biological groupings as well as separate break downs
of the make up the signaling and metabolism groups into separate
components that make up these grouping are presented. Table
S1A Tabular percentages as assessed for the three groups (UP,
Down, Varaible). Table S1B Identified Biological Groups Up.
Table S1C Identified Biological Groups Down. Table S1D
Identified Biological Groups Variable.
Found at: doi:10.1371/journal.pone.0005393.s002 (0.08 MB
XLS)
Table S2 Identified Biological Ontologies Used To Define the
Percentages of Functional Activities Seen in Commonly Expressed
Genes Between Fracture Healing and Those that Are Preferen-
tially Expressed in ESCs. Table S2 presents the individual
biological processes that were grouped together for presentation
in Figure 4. The percentages for representative ontology groups
that were identified using DAVID were determined for the total
complement of expressed genes contained in the up, down and
variable group of clusters (Table 4). Only those categories of
biological processes with p#.05 were considered and were sorted
into categories representative of overlapping processes. The
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individual genes were identified for each biological process in a
given group and a complete list of all genes was compiled for each
category and all duplicates were removed. For this analysis the
Variable and UP clusters were grouped together into a single
category denoted as UP. The percentage of each category was
computed by the genes per category over the total number of
genes for the cluster subgroups. Table S2A: Identified Biological
Groups Up and Variable (Consolidated into UP). Table S2B:
Identified Biological Groups Down.
Found at: doi:10.1371/journal.pone.0005393.s003 (0.08 MB
XLS)
Table S3 Tabular Summary of the Expressed Genes Across the
Time Course of Fracture Healing. Expressed gene sets are
arranged by numeric cluster from the CAGED analysis. Unigene
number, short letter gene name and gene name are denoted. Two
sets of values are presented: Log ratio intensity values based on
normalization to Day 0 no fracture: Log ratio intensity values
based on normalization to the in spike alien sequence control. The
sequence of each oligonucleotide is presented for assessments of
nature of splice variants. These data are broken down to identify
the subsets that was filtered and used for the clustering analysis.
The externally normalized expression values to the co spotted
alien sequence can be used to extrapolate copy number of
expressed genes in the bone tissues. Approximately ,10% of the
gene descriptors in the array represent multiple splice variants that
can be deduced from the nucleotide sequences (Table S3). The
major biological themes that tracked with individual clusters may
be identified by self examination of the clusters by assessments of
the expressed genes in the cluster with DAVID. As one example,
all of the major extracellular matrix proteins associated with
cartilage tissue formation (col2a1, col9a1,2,3, col10a1, and
aggrecan) tracked in cluster one. Table S3A: Tabular list of those
genes that were spotted on the array which met inclusion criteria
for use in the cluster analysis. Table S3B: Tabular list of gene
expression data that did not meet criteria for inclusion in the
cluster analysis but which were shown to have met the criteria for
measurable expression. Table S3C: Tabular list of those genes that
were spotted on the array but which did not meet inclusion criteria
for measurable expression.
Found at: doi:10.1371/journal.pone.0005393.s004 (8.49 MB
XLS)
Table S4 Expression Characteristics of Known Genes Associat-
ed With Skeletal Disorders During Fracture Healing [37]. The list
of skeletal disorders as summarized in Superti-Furga and Unger,
2007, was compared to those expressed genes seen in fracture
healing. The observed list is arranged based on the classification
scheme presented by Superti-Furga and Unger, 2007. The listing
of the data was sorted based on association with: temporal cluster;
Cluster group (Up, down or variable); Specific developmental
ontologies (neurogenesis N, vasculogenesis V or skeletogenesis S; a
simplified pathological classification: Brachydactylies BD; CF
cranial facial; Dysostosis DP; epiphyseal or epiphyseal dysplasias
EM; Generalized or multi-tissue dysplasias GDP; limb length
differences LL; mineralization defects M; Polydactyly or Syndac-
tyly; PS, synostoses SYN; or Vertebra or rib VR.
Found at: doi:10.1371/journal.pone.0005393.s005 (0.13 MB
XLS)
Table S5 Summary of the Expression of FGF Morphogenetic
Family and Receptors Across the Time Course of Fracture
Healing. The FGF morphogens and the FGF receptor are
summarized based on clusters in which they are associated.
Expressed genes are arranged by numeric cluster from the
CAGED analysis. Unigene number, short letter gene name and
gene name are denoted. Two sets of values are presented: Log
ratio intensity values based on normalization to Day 0 no fracture:
Log ratio intensity values based on normalization to the in spike
alien sequence control. The sequence of each oligonucleotide is
presented for assessments of nature of splice variants. Groupings of
clusters are arranged by their temporal profiles in a similar manner
as described for Table 3. Clusters showing continuous increases in
gene expression are indicated by C: Clusters showing a biphasic
pattern in gene expression are indicated by B: Clusters showing
increased gene expression at middle time points 5 and 10 days post
fracture are indicated by M: Clusters showing increased gene
expression at late points 14 and 21 days post fracture are indicated
by L. Clusters showing decreased gene expression throughout the
post fracture period are indicated by D.
Found at: doi:10.1371/journal.pone.0005393.s006 (0.03 MB
XLS)
Table S6 Tabular Summaries of the Expressed Genes across the
Time Course of Fracture Healing Showing Overlap With Those
Preferentially Expressed in ESC, Embryonic MSCs or Post Natal
MSCs. The overlap of those genes showing differential expression
during the time course of fracture healing to three published gene
sets of those showing preferential expression in ESCs and MSCs
[35,59,60]. Expressed genes are arranged by numeric cluster from
the CAGED analysis. Unigene number, short letter gene name
and gene name are denoted. Two sets of values are presented: Log
ratio intensity values based on normalization to Day 0 no fracture:
Log ratio intensity values based on normalization to the in spike
alien sequence control. The sequence of each oligonucleotide is
presented for assessments of nature of splice variants. ESC:
Expressed genes overlapping between those preferential to ESC
and showing altered expression in fracture healing. MSC:
Expressed genes overlapping between those preferential to post
natal MSCs and showing altered expression in fracture healing.
EMSC: Expressed genes overlapping between those preferential to
embryonic MSCs and showing altered expression in fracture
healing.
Found at: doi:10.1371/journal.pone.0005393.s007 (0.35 MB
XLS)
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